{"id":"https://openalex.org/W2005993459","doi":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","title":"On the pharmacology and biochemistry of the amine\u2010uptake mechanism in human blood platelets","display_name":"On the pharmacology and biochemistry of the amine\u2010uptake mechanism in human blood platelets","alternate_titles":[],"publication_year":1973,"publication_date":"1973-10-01","ids":{"openalex":"https://openalex.org/W2005993459","doi":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","mag":"2005993459","pmid":"https://pubmed.ncbi.nlm.nih.gov/4152219","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1776386"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1973.tb08373.x","doi":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1973.tb08373.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005993459"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1973.tb08373.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110221517","display_name":"Iain C. Campbell","orcid":"https://orcid.org/0000-0003-2776-2681","observed_orcids":["https://orcid.org/0000-0003-2776-2681"]},"institutions":[{"id":"https://openalex.org/I2802899753","display_name":"Crichton Royal Hospital","ror":"https://ror.org/014tckg45","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802899753"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I. C. CAMPBELL","raw_affiliation_strings":["Department of Clinical Research, Crichton Royal Hospital, Dumfries DG1 4TG, Scotland","Department of Psychological Medicine, The University of Newcastle upon Tyne NE1 4LP, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research, Crichton Royal Hospital, Dumfries DG1 4TG, Scotland","institution_ids":["https://openalex.org/I2802899753"]},{"raw_affiliation_string":"Department of Psychological Medicine, The University of Newcastle upon Tyne NE1 4LP, England","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004502022","display_name":"Archibald Todrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802899753","display_name":"Crichton Royal Hospital","ror":"https://ror.org/014tckg45","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802899753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. TODRICK","raw_affiliation_strings":["Department of Clinical Research, Crichton Royal Hospital, Dumfries DG1 4TG, Scotland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research, Crichton Royal Hospital, Dumfries DG1 4TG, Scotland","institution_ids":["https://openalex.org/I2802899753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.5705,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.88423038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"49","issue":"2","first_page":"279","last_page":"287"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.19059999287128448,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.1429000049829483,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-uptake","display_name":"serotonin uptake","score":0.9350000023841858},{"id":"https://openalex.org/keywords/platelets","display_name":"platelets","score":0.7680000066757202},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.9120000004768372},{"id":"https://openalex.org/keywords/prenylamine","display_name":"prenylamine","score":0.7799999713897705},{"id":"https://openalex.org/keywords/phenoxybenzamine","display_name":"phenoxybenzamine","score":0.9229999780654907},{"id":"https://openalex.org/keywords/iodoacetic-acid","display_name":"iodoacetate","score":0.8169999718666077},{"id":"https://openalex.org/keywords/p-chloromercuribenzoate","display_name":"p-chloromercuribenzoate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ouabain","display_name":"ouabain","score":0.9100000262260437},{"id":"https://openalex.org/keywords/potassium-dependence","display_name":"potassium dependence","score":0.796999990940094},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.8169999718666077},{"id":"https://openalex.org/keywords/adrenergic-drugs","display_name":"adrenergic drugs","score":0.7860000133514404},{"id":"https://openalex.org/keywords/oxidative-phosphorylation-inhibitors","display_name":"oxidative phosphorylation inhibitors","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.7804790735244751},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.763931393623352},{"id":"https://openalex.org/C2779133857","wikidata":"https://www.wikidata.org/wiki/Q285911","display_name":"Ouabain","level":3,"score":0.6653670072555542},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6563819050788879},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6417243480682373},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.5689002275466919},{"id":"https://openalex.org/C2780668150","wikidata":"https://www.wikidata.org/wiki/Q419824","display_name":"Phenoxybenzamine","level":3,"score":0.5665762424468994},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.511742115020752},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5105198621749878},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.45457619428634644},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4148877263069153},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41117990016937256},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22296109795570374},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.16705086827278137},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1635633409023285},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16292676329612732},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11398020386695862},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.07779988646507263},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000433","descriptor_name":"1-Propanol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001693","descriptor_name":"Biological Transport, Active","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004877","descriptor_name":"Ergoloid Mesylates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004878","descriptor_name":"Ergotamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007461","descriptor_name":"Iodoacetates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007488","descriptor_name":"Iprindole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007545","descriptor_name":"Isoproterenol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008274","descriptor_name":"Magnesium","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010042","descriptor_name":"Ouabain","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010643","descriptor_name":"Phenoxybenzamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010646","descriptor_name":"Phentolamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012964","descriptor_name":"Sodium","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1973.tb08373.x","doi":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1973.tb08373.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:4152219","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4152219","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1776386","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1776386/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1973.tb08373.x","doi":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1973.tb08373.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1973.tb08373.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005993459.pdf","grobid_xml":"https://content.openalex.org/works/W2005993459.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W53701242","https://openalex.org/W330527047","https://openalex.org/W1441180467","https://openalex.org/W1978163057","https://openalex.org/W1983115849","https://openalex.org/W2016274166","https://openalex.org/W2024228356","https://openalex.org/W2032887415","https://openalex.org/W2037409324","https://openalex.org/W2044270690","https://openalex.org/W2055448267","https://openalex.org/W2057327534","https://openalex.org/W2060286184","https://openalex.org/W2075986534","https://openalex.org/W2088753926","https://openalex.org/W2093551180","https://openalex.org/W2139241332","https://openalex.org/W2320154010","https://openalex.org/W2471116424","https://openalex.org/W2796697875","https://openalex.org/W2808137354","https://openalex.org/W4407724177"],"related_works":["https://openalex.org/W2039444985","https://openalex.org/W2013837049","https://openalex.org/W2022064538","https://openalex.org/W2093551180","https://openalex.org/W2003324479","https://openalex.org/W2008948515","https://openalex.org/W1969937228","https://openalex.org/W2084763990","https://openalex.org/W1978301275","https://openalex.org/W2055433027"],"abstract_inverted_index":{"1.":[0],"The":[1],"uptake":[2,122,133],"of":[3,18,33,69,72,126,131,156,168],"5-hydroxytryptamine":[4],"(5-HT)":[5],"by":[6,109],"human":[7],"blood":[8],"platelets":[9,62,93],"in":[10,26,96,101,119,153],"vitro":[11],"has":[12,139,150],"been":[13,151],"studied":[14],"with":[15,60,85],"the":[16,20,41,61,86,92,128,132,135,146,154],"object":[17],"identifying":[19],"biochemical":[21],"mechanisms":[22],"involved.2.":[23],"Drugs":[24],"active":[25,39],"adrenergic":[27],"systems":[28],"are":[29,94],"only":[30],"moderate":[31],"inhibitors":[32],"uptake,":[34,79],"although":[35],"prenylamine":[36],"is":[37,48,56,163],"as":[38,40,51],"less":[42],"potent":[43,166],"tricyclic":[44],"anti-depressive":[45],"drugs;":[46],"phenoxybenzamine":[47],"almost":[49],"inactive":[50],"a":[52,164],"competitive":[53],"inhibitor":[54,167],"but":[55,80,99],"effective":[57],"if":[58,83],"pre-incubated":[59,84],"beforehand.":[63],"This":[64],"parallels":[65],"its":[66,113],"pharmacological":[67],"pattern":[68],"action.3.":[70],"Inhibitors":[71],"oxidative":[73],"phosphorylation":[74],"do":[75],"not":[76,100,144],"inhibit":[77],"5-HT":[78,169],"iodoacetate":[81],"inhibits,":[82],"platelets;":[87],"p-chloromercuribenzoate":[88],"does":[89],"also,":[90],"when":[91],"suspended":[95],"synthetic":[97],"medium,":[98,121],"plasma.4.":[102],"Ouabain":[103],"causes":[104],"significant":[105],"inhibition":[106],"at":[107],"10(-7)M;":[108],"10(-6)M":[110],"it":[111],"achieves":[112],"maximal":[114],"effect,":[115],"namely":[116],"40%":[117],"inhibition;":[118],"K(+)-deficient":[120],"falls":[123],"to":[124],"30%":[125],"normal;":[127],"K(+)-dependent":[129],"fraction":[130],"includes":[134],"ouabain-sensitive":[136],"component.":[137],"Mg(++)":[138],"no":[140],"effect.5.":[141],"A":[142],"drug":[143],"possessing":[145],"imipramine":[147],"structure,":[148],"which":[149],"tried":[152],"treatment":[155],"depressive":[157],"illness,":[158],"4-phenyl":[159],"bicyclo":[160],"(2,2,2)":[161],"octan-1-amine,":[162],"highly":[165],"uptake.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005993459","counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}
